Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)'s focus remains on treating GI disorders, including IBS-C and CIC, with LINZESS, ...

New Delhi: Responding to the proposal presented by Torrent Pharmaceutical to manufacture and market Prucalopride oral ...